Literature DB >> 28669991

Polycystic kidney disease: SMYD2 is a novel epigenetic regulator of cyst growth.

Andrea Aguilar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28669991     DOI： 10.1038/nrneph.2017.99

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  1 in total

1.  Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease.

Authors:  Linda Xiaoyan Li; Lucy X Fan; Julie Xia Zhou; Jared J Grantham; James P Calvet; Julien Sage; Xiaogang Li
Journal:  J Clin Invest       Date:  2017-06-12       Impact factor: 14.808
  1 in total
  1 in total

1.  Overexpression of SET and MYND Domain-Containing Protein 2 (SMYD2) Is Associated with Tumor Progression and Poor Prognosis in Patients with Papillary Thyroid Carcinoma.

Authors:  Wenchao Xu; Fulian Chen; Xiao Fei; Xiaoqing Yang; Xiaofei Lu
Journal:  Med Sci Monit       Date:  2018-10-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.